CEVA, Animal Health, Vaccines, Hatchery Vaccination
Ceva is a global veterinary and animal health company, and is the fastest growing company out of the top ten companies in its field. We specialize in chemical medicine and biology, with a professional team focusing on the development, production and sale of pharmaceutical products and related vaccines applied for poultry, swine, pets and ruminant animals. We have branch offices in 42 countries and 13 R&D centers, 21 production sites and more than 3,000 employees. The R&D teams and industrial production teams work together very closely, allowing the final R&D result to be put into full production very quickly. So far we have established R&D institutions and pharmaceutical centers in France, the United States, Brazil and Italy. Meanwhile, we have founded biological research centers in the United States, Mexico, Brazil, Hungary and Japan.
The China branch of Ceva is devoted to providing necessary technical services for users in mainland China and to building a communication channel between customers and the company's headquarters so as to understand the actual needs of Chinese users more effectively and develop the company’s products according to such research. Ceva have used C.H.I.C.K Program and EGGS Program in China to increase the hatchery vaccination efficiency. Our products in China market include: CEVAC® TRANSMUNE IBD, CEVAC® IBD L, CEVAC® BROILER ND K, CEVAC® GUMBO L, CEVAMUNE®, etc. In the future, Ceva will continue to develop solutions for preventing brucellosis, avian flu and other diseases.
